Arrowhead Research Tumbles 20% Following FDA News

By: via Benzinga
Shares of Arrowhead Research Corp (NASDAQ: ARWR) fell more than 20 percent in Monday’s premarket following news that the U.S. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.